Juvoly B.V.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Juvoly B.V. - overview

Established

2023

Location

Leiden, -, Netherlands

Primary Industry

Software

About

Based in the Netherlands, Juvoly B. V. specializes in AI-driven speech recognition and documentation solutions tailored for the healthcare sector, enhancing efficiency and streamlining patient consultation processes. Juvoly B.


V. provides advanced AI speech recognition and documentation solutions for the healthcare sector. Founded in 2023, the company is headquartered in Leiden, Netherlands. The company was founded by Thomas Kluiters and Maarten Timmers.


In January 2026, Tandem Health AB, a portfolio company of Northzone, Visionaries Club, Amino Collective, and Kinnevik, agreed to acquire Juvoly B. V. Juvoly specializes in AI-driven speech recognition and documentation solutions tailored for the healthcare sector. The company's primary offerings, including QuickConsult and PhoneAssist, streamline the documentation process during patient consultations, allowing healthcare professionals to focus on patient care rather than administrative tasks.


QuickConsult facilitates both in-person and virtual consultations and integrates with various Electronic Patient Records (EPR) systems, while PhoneAssist is designed for efficient documentation of telephone consultations. These products serve a diverse client base, including over one-third of Dutch general practitioners and a wide range of healthcare professionals across the Netherlands. Juvoly's solutions are built to address common challenges in healthcare documentation, including language barriers and the need for quick access to medical resources, operating primarily within the Dutch market but also extending through its multilingual capabilities to support healthcare providers serving diverse populations. Juvoly generates revenue through a subscription-based model for its flagship products, QuickConsult and PhoneAssist.


For QuickConsult, pricing includes a 14‑day free trial, after which individual users pay approximately EUR 65 per month, while GP practices can opt for unlimited team usage at ~ EUR 0. 65 per ION/year under annual plans. For PhoneAssist, pricing varies by integration partner, including EUR 0. 35 per ION/year (via Vcare & Advitronics), EUR 75 per FTE per year (via Call Lotte, with volume discounts), or usage‑based/variable pricing (via LanTel & Plainwise).


Clients, primarily healthcare organizations and professionals, subscribe to these services to benefit from automated documentation capabilities which facilitate efficient patient interactions. The transactional structure is designed to simplify administrative tasks, allowing providers to enhance their focus on patient care.


Current Investors

Tandem Health AB

Primary Industry

Software

Sub Industries

Analytics & Performance Software, Medical Software

Website

www.juvoly.nl/

Verticals

Artificial Intelligence, Cloud Computing, HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.